Biosimilars Resources

 

The Biosimilars Generation website provides you with links to information about biosimilar regulations and policies in Canada.

 
Regulators

Health Canada and other Canadian government regulators provide guidance on the safety, efficacy and quality of biologic (original-brand and biosimilar) medicines.

Biosimilars Reimbursement Access info

Public payers are adopting biosimilar policies that affect Canadians living with many disabling and life-threatening chronic diseases, such as inflammatory arthritis, certain types of cancer, diabetes, inflammatory bowel disease, Crohn’s disease and psoriasis.

Find more information about biosimilars and their listings on public drug plans.

Public Payers

For up-to-date information about biosimilars transition policy for each public formulary, please visit the websites below:


British Columbia

Biosimilars Initiative for Patients
BC PharmaCare


Alberta

Alberta Biosimilars Initiative
Alberta Blue Cross: Government Sponsored Biosimilars Initiative


Saskatchewan

Saskatchewan Biosimilars Initiative
Saskatchewan Formulary


Manitoba

Notice – Tiered Biologics Reimbursement Policy
Provincial Drug Formulary


Ontario

Ontario Health and Leslie Dan Faculty of Pharmacy, University of Toronto: Foundations of Originator and Biosimilar Biologics: for Patients and Caregivers
Ontario Ministry of Health. Executive Office Notice: Biosimilar Policy
Ontario Formulary
Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs


Quebec

Quebec Health
Government of Quebec: Prescription Drug Insurance - Coverage of Biosimilar Drugs
List of Medications


Nova Scotia

Nova Scotia biosimilars initiative
Nova Scotia Formulary


New Brunswick

New Brunswick Biosimilars Initiative
New Brunswick Biosimilars Initiative – Information for Patients


Newfoundland and Labrador

NLPDP Biosimilar Initiative
Newfoundland and Labrador Department of Health and Community Services
Newfoundland and Labrador Formulary


Prince Edward Island

Health PEI
PEI Formulary


Yukon

Government of Yukon: Supporting your patients switching to a biosimilar
Yukon Health and Social Services
Yukon Formulary


Non-insured Health Benefits (NIHB)

Indigenous Health
Non-Insured Health Benefits Program Updates

Patient groups & organizations

Patient organizations are a good source of support and “easy-to-read” information about medicines, including biologics (original-brand and biosimilars).

Biologic (original-brand and biosimilar) manufacturer associations

Biologic (original-brand and biosimilar) manufacturer associations provide information on biologic medicines.

Buy now